KOL Health

About KOL Health

KOL HEALTH INC.

Key Opinion Leaders in Creating Awareness

Murray Awde, Founder of Key Opinion Leaders
Dr. Murray Awde, C.C.F.P., F.C.F.P
Founder and Chief Operating Officer of Key Opinion Leaders (KOL Health)

KOL Health is comprised of a diverse group of Canadian primary care physicians, specialists, pharmacists, physiotherapists, and audiologists who have received national recognition in the production of continuing education programs.  Group members offer valuable resources, educational and marketing services for pharmaceutical corporations and health marketing agencies either in person or online.

KOL Health currently has physician representatives from Windsor, Sudbury, Greater London area, Cambridge, Oakville, Hamilton, Greater Toronto area, Ottawa, Hawkesbury, Winnipeg and Saskatoon.

The Chief Operating Officer of KOL Health is Dr. Murray Awde C.C.F.P., F.C.F.P., a primary care physician in London, Ontario. He is an Adjunct Clinical Professor of Family Medicine at the University of Western Ontario in London and has participated in more than fifty clinical trials during his thirty years of practice.

Dr. Awde is principle author of Practice Based Teaching modules through the Foundation of Medical Practices at McMaster University in Hamilton and is a member in good standing of the College of  Physicians and Surgeons of Ontario, College of Family Physicians of Canada, the International Society of Hypertension in the United Kingdom and. member of European Association for Diabetes.  He has extended clinical expertise in cosmetic enhancement, infertility, hypertension, and geriatric medicine.

Information found through the KOL Health Web site is valuable to pharmaceutical companies, clinical trial recruiters, medical marketing agencies and focus groups for their projects as it provides resources and links to:

  • Teleconferences for companies, webconferences and members for advisory boards.
  • Key opinion leaders provide a group of physicians to do clinical trials.
  • Clinical information on treatments.
  • Advice on newer medications and their indications.
  • Tips from many practitioners to help provide quality primary care.
  • Opinions on the latest clinical trial data for primary caregivers.

To inquire about our consultative packages, contact KOL Health.

More Articles
  • Weight Loss Success Tips


  • “SICK DAY” MEDICATION ADVICE:


  • New article: European Society for Hypertension

    I attended the meeting of European Society for Hypertension in Oslo Norway, during June 18 - 21, 2010.

    I note this year there were no new blockbuster drugs released at the time of the meeting nor were there any major clinical trials released for review.

    There was lots of practical information related to obesity, salt intake and exercise in the management and treatment of hypertension as well as several excellent lectures on different aspects of hypertension and newer combinations of medications such as Coversyl with amlodipine (Coveram) and Nifedipine and Telmisartan.

  • Microalbuminuria Screening

    A Comparative Evaluation of Various Methods for Microalbuminuria Screening

    Dr. Bakris and I met at a recent ASN meeting and discussed a tool that can be used in primary care screening for nephropathy. Subsequent to that, Dr. Bakris wrote the paper below with the screening device utilized in the trial.


    - Dr Murray Awde




    A Comparative Evaluation of Various Methods for Microalbuminuria Screening



    Pantelis A. Sarafidis a, c Jessica Riehle a Zvezdana Bogojevic a Emad Basta a Atul Chugh b George L. Bakris b



    a Hypertension/Clinical Research Center, Department of Preventive Medicine, Rush University Medical Center, and b Hypertensive Diseases Unit, Section of Endocrinology, Diabetes and Metabolism, University of Chicago-Pritzker School of Medicine, Chicago, Ill. , USA; c Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA University Hospital, Aristotle University of Thesaloniki, Thessaloniki , Greece



    Key Words - Urinary albumin excretion, Hypertension, Diabetes, Kidney disease



    Abstract



    Background/Aims: Microalbuminuria is a marker of abnormal vascular response and a predictor of cardiovascular morbidity and mortality. We evaluated a new quantitative office-based method to assess urinary albumin excretion (UAE) and compared it to other established methods.


More Articles Questions Our Contributors

Site developer: In House Logic ©2009 - 2012 KOL Health Inc. Privacy Policy Mobile: m.kolhealth.com